Purification of monoclonal anti-B7-H4 antibody and the blockade of B7-H4-mediated tumor immune evasion by the antibody

CHEN Yali; LI Anqi; ZHANG Ningyue; ZHANG Liang

doi:10.11665/j.issn.1000-5048.20170411

Journal of China Pharmaceutical University > 2017 > 48(4): 461-468. > DOI: 10.11665/j.issn.1000-5048.20170411

CHEN Yali, LI Anqi, ZHANG Ningyue, ZHANG Liang. Purification of monoclonal anti-B7-H4 antibody and the blockade of B7-H4-mediated tumor immune evasion by the antibody[J]. Journal of China Pharmaceutical University, 2017, 48(4): 461-468. DOI: 10.11665/j.issn.1000-5048.20170411

Citation:

PDF (3424 KB)

Purification of monoclonal anti-B7-H4 antibody and the blockade of B7-H4-mediated tumor immune evasion by the antibody

More Information

Graphical Abstract

Abstract

Abstract

The purified 3C8 was obtained by two step column purification, including Protein G affinity purification and DEAE anion exchange purification. The purity of purified 3C8 was about 93% when analyzed by reverse column. SDS-PAGE showed that the purity of 3C8 was increased greatly by two step purification. By flowcytometry we found that 3C8 specifically binded with B7-H4/293T cells and did not bind with Mock/293T cells, moreover 3C8 did not bind with other B7 family members transgene cells. In confocal experiment 3C8 could specifically stained B7-H4/293T cells. In Western blot only B7-H4/293T cells showed positive band while Mock/293T cells showed negative result. The result of immunohistochemistry showed that B7-H4 was highly expressed in prostate cancer and renal cell carcinoma, while para-cancer tissues did not express B7-H4. The T cell proliferation experiment showed that B7-H4-Ig could bind to activate T cells and inhibit T cell proliferation, while 3C8 could block the binding of B7-H4-Ig and reverse the T cell proliferation inhibition effect of B7-H4-Ig by CFSE and CCK8 assay. The cytokine IFN-γ and IL-2 secreted by activating T cells was decreased by B7-H4-Ig and 3C8 could reverse the effect of B7-H4-Ig.
- monoclonal antibody 3C8,
- B7-H4,
- purification,
- negative costimulation,
- immune evasion,
- blockade

FullText(HTML)

References (15)

References

[1]	Bretscher PA.A two-step,two-signal model for the primary activation of precursor helper T cells[J].Proc Natl Acad Sci U S A,1999,96(1):185-190.
[2]	Schildberg FA,Klein SR,Freeman GJ,et al.Coinhibitory pathways in the B7-CD28 ligand-receptor family[J].Immunity,2016,44(5):955-972.
[3]	Swaika A,Hammond WA,Joseph RW.Current state of anti-PD-L1 and anti-PD-1 agents in cancer therapy[J].Mol Immunol,2015,67(2 Pt A):4-17.
[4]	Sica GL,Choi IH,Zhu G,et al.B7-H4,a molecule of the B7 family,negatively regulates T cell immunity[J].Immunity,2003,18(6):849-861.
[5]	Prasad DV,Richards S,Mai XM,et al.B7S1,a novel B7 family member that negatively regulates T cell activation[J].Immunity,2003,18(6):863-873.
[6]	Zang X,Loke P,Kim J,et al.B7x:a widely expressed B7 family member that inhibits T cell activation[J].Proc Natl Acad Sci U S A,2003,100(18):10388-10392.
[7]	Awadallah NS,Shroyer KR,Langer DA,et al.Detection of B7-H4 and p53 in pancreatic cancer:potential role as a cytological diagnostic adjunct[J].Pancreas,2008,36(2):200-206.
[8]	Miyatake T,Tringler B,Liu W,et al.B7-H4(DD-O110)is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration[J].Gynecol Oncol,2007,106(1):119-127.
[9]	Podojil JR,Miller SD.Potential targeting of B7-H4 for the treatment of cancer[J].Immunol Rev,2017,276(1):40-51.
[10]	Ni L,Dong C.New B7 family checkpoints in human cancers[J].Mol Cancer Ther,2017,16(7):1203-1211.
[11]	MacGregor HL,Ohashi PS.Molecular pathways:evaluating the potential for B7-H4 as an immunoregulatory target[J].Clin Cancer Res,2017,23(12):2934-2941.
[12]	Jeon H,Vigdorovich X,Garrett-Thomson SC,et al.Structure and cancer immunotherapy of the B7 family member B7x[J].Cell Rep,2014,9(3):1089-1098.
[13]	Dangaj D,Lanitis E,Zhao A,et al.Novel recombinant human b7-h4 antibodies overcome tumoral immune escape to potentiate T-cell antitumor responses[J].Cancer Res,2013,73(15):4820-4829.
[14]	Dangaj D,Scholler N.Isolation and validation of Anti-B7-H4 scFvs from an ovarian cancer scFv yeast-display library[J].Methods Mol Biol,2015,1319:37-49.
[15]	Leong SR,Liang WC,Wu Y,et al.An anti-B7-H4 antibody-drug conjugate for the treatment of breast cancer[J].Mol Pharm,2015,12(6):1717-1729.

Cited By

Get Citation

PDF

XML

Article views (638) PDF downloads (1389)

Turn off MathJax

Article Contents

Abstract

References

Purification of monoclonal anti-B7-H4 antibody and the blockade of B7-H4-mediated tumor immune evasion by the antibody

Abstract

References

Catalog

Export File

Citation

Format

Content